The Effects of Carbohydrate-electrolyte Solution on Metabolic Responses in Paediatric Patients
NCT ID: NCT05729100
Last Updated: 2023-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
110 participants
INTERVENTIONAL
2023-01-01
2023-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of 1 Hour Clear Fluid Fasting Prior to Paediatric GA
NCT03952260
Phase III Randomized Study of Sodium Dichloroacetate in Children With Congenital Lactic Acidosis
NCT00004490
Exogenous Ketone Esters for Refractory Status Epileptics
NCT05674552
High vs Standard Energy Children's Drink Study
NCT02419599
Assessment of Pre Hospital Rescue Intervention for Seizure in Pediatric Patients
NCT06723431
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oral carbohydrate-electrolyte solution
The intervention group who will receive 50 ml/kg of oral solution containing carbohydrate-electrolyte
Oral carbohydrate-electrolyte solution
Oral solution containing 10% glucose and electrolyte (in every 300 ml of fluid (contains 30 gr dextrose, 150 mg Natrium chloride, 366 mg Kalium chloride)
Standard clear fluid
The control group who will receive 50 ml/kg of clear fluid (i.e. water; which does not contain carbohydrate-electrolyte)
Control
Standard clear fluid (water)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral carbohydrate-electrolyte solution
Oral solution containing 10% glucose and electrolyte (in every 300 ml of fluid (contains 30 gr dextrose, 150 mg Natrium chloride, 366 mg Kalium chloride)
Control
Standard clear fluid (water)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with physical status according to American Society of Anesthesiologists (ASA) 1 or 2
* Patients undergoing surgery with general anesthesia with or without regional anesthesia
* Has a relatively good enteral tolerability
Exclusion Criteria
* Patients requiring Pediatric intensive care unit (PICU) for post operative care and is likely to remain intubated following the end of the surgery
* Patients who receive antiemetic therapy within 24 hours before the surgery
* Patients undergoing cardiac surgery or neurosurgery
1 Month
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indonesia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andi Ade Wijaya Ramlan
Principle Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ciptomangun Kusumo Hospital
Jakarta, DKI Jakarta, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Andi Ade Wijaya Ramlan, Doctorate
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IndonesiaUAnes210
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.